Albert Herms

Albert Herms

Auto-generated profile, based on publicly available information

Albert Herms

Wellcome Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AKAdam Kassan
Adam Kassan
AHAlbert Herms
Albert Herms
AFAndrea Fernández-Vidal
Andrea Fernández-Vidal
MBMarta Bosch
Marta Bosch
NSNicole L. Schieber
Nicole L. Schieber
APAlbert Pol
Albert Pol
Control of lipid droplet (LD) nucleation and copy number are critical, yet poorly understood, processes. We use model peptides that shift from the endoplasmic reticulum (ER) to LDs in response to fatty acids to characterize the initial steps of LD formation occurring in lipid-starved cells. Initially, arriving lipids are rapidly packed in LDs that are resistant to starvation (pre-LDs). Pre-LDs are restricted ER microdomains with a stable core of neutral lipids. Subsequently, a first round of “emerging” LDs is nucleated, providing additional lipid storage capacity. Finally, in proportion to lipid concentration, new rounds of LDs progressively assemble. Confocal microscopy and electron tomography suggest that emerging LDs are nucleated in a limited number of ER microdomains after a synchronized stepwise process of protein gathering, lipid packaging, and recognition by Plin3 and Plin2. A comparative analysis demonstrates that the acyl-CoA synthetase 3 is recruited early to the assembly sites, where it is required for efficient LD nucleation and lipid storage.

27 May 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
AHAlbert Herms
Albert Herms
MBMarta Bosch
Marta Bosch
BRBabu J.N. Reddy
Babu J.N. Reddy
NSNicole L. Schieber
Nicole L. Schieber
AFAlba Fajardo
Alba Fajardo
APAlbert Pol
Albert Pol
Lipid droplets (LDs) are intracellular organelles that provide fatty acids (FAs) to cellular processes including synthesis of membranes and production of metabolic energy. While known to move bidirectionally along microtubules (MTs), the role of LD motion and whether it facilitates interaction with other organelles are unclear. Here we show that during nutrient starvation, LDs and mitochondria relocate on detyrosinated MT from the cell centre to adopt a dispersed distribution. In the cell periphery, LD–mitochondria interactions increase and LDs efficiently supply FAs for mitochondrial beta-oxidation. This cellular adaptation requires the activation of the energy sensor AMPK, which in response to starvation simultaneously increases LD motion, reorganizes the network of detyrosinated MTs and activates mitochondria. In conclusion, we describe the existence of a specialized cellular network connecting the cellular energetic status and MT dynamics to coordinate the functioning of LDs and mitochondria during nutrient scarcity.

1 August 2013 in Current Biology
Verified
Journal Article
Closed access
AHAlbert Herms
Albert Herms
MBMarta Bosch
Marta Bosch
NANick Ariotti
Nick Ariotti
BRBabu J.N. Reddy
Babu J.N. Reddy
AFAlba Fajardo
Alba Fajardo
APAlbert Pol
Albert Pol

1 April 2011 in Current Biology
Verified
Journal Article
Closed access
MBMarta Bosch
Marta Bosch
Montserrat MariMontserrat Mari
Montserrat Mari
AHAlbert Herms
Albert Herms
AFAna Fernández
Ana Fernández
AFAlba Fajardo
Alba Fajardo
APAlbert Pol
Albert Pol

19 January 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EAEmilie Abby
Emilie Abby
SDStefan C. Dentro
Stefan C. Dentro
MHMichael W. J. Hall
Michael W. J. Hall
JFJoanna C. Fowler
Joanna C. Fowler
SOSwee Hoe Ong
Swee Hoe Ong
PJPhilip H. Jones
Philip H. Jones
NOTCH1 mutant clones occupy the majority of normal human esophagus by middle age but are comparatively rare in esophageal cancers, suggesting NOTCH1 mutations drive clonal expansion but impede carcinogenesis. Here we test this hypothesis. Sequencing NOTCH1 mutant clones in aging human esophagus reveals frequent biallelic mutations that block NOTCH1 signaling. In mouse esophagus, heterozygous Notch1 mutation confers a competitive advantage over wild-type cells, an effect enhanced by loss of the second allele. Widespread Notch1 loss alters transcription but has minimal effects on the epithelial structure and cell dynamics. In a carcinogenesis model, Notch1 mutations were less prevalent in tumors than normal epithelium. Deletion of Notch1 reduced tumor growth, an effect recapitulated by anti-NOTCH1 antibody treatment. Notch1 null tumors showed reduced proliferation. We conclude that Notch1 mutations in normal epithelium are beneficial as wild-type Notch1 favors tumor expansion. NOTCH1 blockade may have therapeutic potential in preventing esophageal squamous cancer.

1 September 2019 in Cell Stem Cell
Verified
Journal Article
Open access
DFDavid Fernandez-Antoran
David Fernandez-Antoran
GPGabriel Piedrafita
Gabriel Piedrafita
KMKasumi Murai
Kasumi Murai
SOSwee Hoe Ong
Swee Hoe Ong
AHAlbert Herms
Albert Herms
PJPhilip H. Jones
Philip H. Jones
As humans age, normal tissues, such as the esophageal epithelium, become a patchwork of mutant clones. Some mutations are under positive selection, conferring a competitive advantage over wild-type cells. We speculated that altering the selective pressure on mutant cell populations may cause them to expand or contract. We tested this hypothesis by examining the effect of oxidative stress from low-dose ionizing radiation (LDIR) on wild-type and p53 mutant cells in the transgenic mouse esophagus. We found that LDIR drives wild-type cells to stop proliferating and differentiate. p53 mutant cells are insensitive to LDIR and outcompete wild-type cells following exposure. Remarkably, combining antioxidant treatment and LDIR reverses this effect, promoting wild-type cell proliferation and p53 mutant differentiation, reducing the p53 mutant population. Thus, p53-mutant cells can be depleted from the normal esophagus by redox manipulation, showing that external interventions may be used to alter the mutational landscape of an aging tissue.